IMARC Group's report titled "COPD and Asthma Devices Market Report by Product (Inhalers, Nebulizers), Indication (Asthma, COPD), Distribution Channel (Retail Pharmacies, Hospitals, Online Pharmacies), and Region 2024-2032". The global COPD and asthma devices market size reached US$ 45.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 69.5 Billion by 2032, exhibiting a growth rate (CAGR) of 4.6% during 2024-2032.
Grab a sample PDF of this report: https://www.imarcgroup.com/copd-asthma-devices-market/requestsample
Factors Affecting the Growth of the COPD and Asthma Devices Industry:
Increasing Prevalence of Respiratory Diseases:
The rising occurrence of respiratory diseases among the masses, attributed to a combination of factors, including air pollution, smoking, and changing lifestyle habits, is bolstering the market growth. Urbanization is leading to higher levels of air pollutants, such as particulate matter and nitrogen dioxide, which exacerbate respiratory conditions. Furthermore, the growing smoking population is contributing to the incidence of chronic obstructive pulmonary disease (COPD) and asthma. These factors are catalyzing the demand for effective and convenient respiratory devices, including inhalers and nebulizers, to manage and treat these conditions. Healthcare systems and patients are seeking more efficient treatment options, which is driving the need for COPD and asthma devices.
Technological Advancements in Device Manufacturing:
Innovations in device design and functionality, such as the development of smart inhalers equipped with Bluetooth technology, offer enhanced drug delivery efficiency and patient adherence through features like usage tracking and reminders. Manufacturers are focusing on creating compact, user-friendly devices that improve the quality of life for patients with respiratory conditions. These advancements not only cater to the demand for more efficient treatment options but also support the shift towards personalized medicine. The continuous technological evolution is leading to the adoption of advanced COPD and asthma devices with enhanced features.
Rise in Geriatric Population:
Older adults are more susceptible to chronic respiratory diseases due to the natural decline in lung function with age, compounded by factors, such as a history of smoking and increased vulnerability to air pollutants. This demographic shift is leading to a higher incidence of COPD and asthma, thereby catalyzing the demand for respiratory care devices. The need for easy-to-use and effective treatment options for older people is encouraging innovation and adoption of devices specifically designed to cater to this age group. The growing aging population is driving the demand for COPD and asthma devices.
Explore full report with table of contents: https://www.imarcgroup.com/copd-asthma-devices-market
Leading Companies Operating in the Global COPD and Asthma Devices Industry:
Adherium Limited
Aristopharma Ltd.
AstraZeneca PLC
Baxter International Inc.
Boehringer Ingelheim International GmbH
Cohero Health Inc.
Koninklijke Philips N.V.
Omron Corporation
Pari Respiratory Equipment Inc.
Recipharm AB
Verona Pharma plc
COPD and Asthma Devices Market Report Segmentation:
By Product:
Inhalers
Drug Powdered Inhalers (DPIs)
Metered Dose Inhalers (MDIs)
Soft Mist Inhalers
Nebulizers
Compressor Nebulizers
Ultrasonic Nebulizers
Mesh Nebulizers
Inhalers exhibit a clear dominance in the marker due to their ease of use, portability, and the immediate relief they provide to users experiencing respiratory difficulties.
By Indication:
Asthma
COPD
Asthma represents the largest segment owing to its higher prevalence among the masses through factors, such as air pollution and genetic predisposition.
By Distribution Channel:
Retail Pharmacies
Hospitals
Online Pharmacies
Retail pharmacies hold the biggest market share, as they are the most accessible source for patients to obtain their prescribed devices.
Regional Insights:
North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa
North America dominates the market owing to the presence of an advanced healthcare infrastructure and the rising prevalence of respiratory conditions within its population.
Global COPD and Asthma Devices Market Trends:
The advent of connected devices and health applications is transforming patient care by enabling remote monitoring and management of chronic respiratory conditions. These digital tools collect data on medication usage, adherence rates, and symptom patterns, facilitating personalized treatment plans and proactive healthcare interventions.
Additionally, the growing focus on developing combination therapies, which involve the use of advanced devices delivering multiple medications, is offering enhanced convenience and improved outcomes for patients. This is complemented by the rise of precision medicine approaches in treating respiratory diseases, where genetic and biomarker information is used to tailor treatments to individual patients.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145